Tandem Diabetes announced clinical trial results that showed from the very first day, children with type 1 diabetes who used the Control-IQ hybrid closed loop technology...

How does technology shape the experiences of those with diabetes? From access to healthcare to data collection, the advances of the digital age have left a significant...

The FDA has cleared Abbott's Freestyle Libre 2 and Libre 3 continuous glucose monitors (CGM) for integration with automated insulin delivery (AID) systems. These devices...

Medicare will begin covering continuous glucose monitors (CGMs) for a broader group of T2D patients beginning in April.

Researchers at ATTD 2023 discussed some of the latest advancements in non-invasive glucose monitoring, including two new approaches to tackling this challenge.

A closed-loop system enables your CGM to communicate with your insulin pump to adjust your insulin dosage throughout the day. Researchers at ATTD 2023 presented the...

New research from diaTribe and market research firm, dQ&A, is looking to explore how diabetes stigma might be impacting people’s willingness to use insulin pumps and...

At the ATTD 2023 conference, panelists during the #dedocº Symposium highlighted how access and personalization impacts people with diabetes’ uptake and use of diabetes...

On the opening morning of the ATTD 2023 conference, several leading clinicians from across Europe gathered to discuss the future of continuous glucose monitoring (CGM)...

Every word in this article was written by ChatGPT (not a human). To create this article, we asked it questions about using ChatGPT in diabetes care. This article,...

Leading clinicians at the ATTD conference discussed the need for greater CGM access for people with type 2 diabetes, as well as those with cystic fibrosis-related...

The long-awaited US launch of Dexcom G7 is here! G7 improves on Dexcom’s current continuous glucose monitoring (CGM) system, the G6, with greater accuracy, smaller size...

The diaTribe team is headed to Berlin, Germany, to cover this year’s Advanced Technologies and Treatments for Diabetes (ATTD) conference! Here’s a preview of some...

During this year’s Super Bowl, Dexcom will air a commercial starring pop star Nick Jonas, announcing the US launch of its latest continuous glucose monitor (CGM), the...

Access to continuous glucose monitors (CGM) can be severely limited. Tamara Oser, a researcher at the University of Colorado, launched PREPARE 4 CGM, a project to...

diaTribe’s own Diane Scherer shares why she is both eager and hesitant as she navigates various diabetes devices over the years and offers tips for trying new technology.

Dexcom and Division I college athletes have teamed up to encourage other people living with diabetes to fully participate in sports.

The FDA approved Proclaim XR, a new implantable spinal cord stimulation device, as a treatment for pain from diabetes-related nerve damage, which affects 1 in 3 people...

The FDA cleared Tidepool Loop for people with type 1 diabetes ages six and up. Tidepool Loop is now the first “do-it-yourself” automated insulin delivery system with...

New study results showed that using an artificial pancreas, or fully closed-loop automated insulin delivery system, improved time spent in a healthy glucose range by...